HomeACADEMIA
ACADEMIA

Kyoto Univ. to Commence Trial of Drug Candidate Discovered in iPS Cells Research for Rare Bone Disease
(Aug.3.2017)

Kyoto University’s Center for iPS Cell Research and Application (CiRA) said on August 1 that it will launch an investigator-initiated trial of the drug candidate rapamycin, an immunosuppressant that was identified in research using iPS Cells created from fibrodysplasia ossificans progressiva (FOP) patients ...
(LOG IN FOR FULL STORY)

Notice

 The next ebook update will be provided on August 28.

News Calendar